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collected light signal provides information on the beam 
profile. A first prototype was developed and tested with 2 
MeV protons [1]. On this basis, a fully motorized device was 
designed and built for the Bern medical cyclotron [2], which 
is used for the production of PET radioisotopes and multi-
disciplinary research activities. The 10 cm long and 400 μm 
diameter sensing fiber is connected with a commercial 
optical fiber transporting the signal outside of the bunker. 
Cerium, antimony doped and non-doped sensing silica fibres 
were used, according to the intensity range. The fibres 
operate in vacuum and the signal is read out by a photo diode 
or by a PMT. The read out device, the control of the motor 
and the DAQ are integrated into a single compact apparatus. 
Results: The UniBEaM detector was tested at the Bern 
medical cyclotron delivering beams from a few pA to 150 μA 
[3]. Two beam profiles are reported in Figure 1, taken at 50 
pA and 1 μA, respectively. Due to their higher light yield, Ce 
doped fibres were used for intensities in the pico- and 
nanoampere range. Here the signal is recorded at successive 
steady positions of the fibre by single photon counting. For 
intensities from 100 nA to 1 μA, Sb doped fibres read out by a 
photodiode were used. The fiber is now moved continuously 
and the amplitude of the signal recorded. From 1 nA to 1 μA, 
the output signal was found to be linear with respect to the 
beam intensity. In this range, the position of the beam can 
be measured with a precision of about 0.1 mm, allowing the 
use of the UniBEaM detector for beam dynamics studies [4]. 
At intensities above 1 μA, a non-doped sensing fibre was 
used. Due to the dependence of the light transmission on 
temperature, the beam profile was found to be distorted, 
with a consequent non-linearity of the signal with respect to 
intensity. Nevertheless, the position of the beam can be 
monitored. This is a key feature for radioisotope production, 
especially if a solid target is used. 
Conclusions: The UniBEaM detector is based on the collection 
of the optical signal produced by an ion beam traversing a 
silica fiber. This device was successfully tested at the Bern 
medical cyclotron at intensities ranging from a few pA to 
about 20 μA, opening the way for its use in the production of 
medical radioisotopes and cancer hadrontherapy. Its 
commercialization is underway. 
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Figure 1 – Beam profiles measured at 50 pA (left) and 1 A 
(right). 
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Microbeam Radiation Therapy (MRT) is a novel technique[1]  
using spatially fractionated, intense, highly collimated, 
parallel arrays of X-ray beams generated at 3rd generation 
synchrotron facilities like the ESRF in Grenoble, France. The 
insertion of an adequate multislit collimator[2] produces 
microbeams with a FWHM between 20 and 100 μm with 
separations between 100 and 400 μm to be delivered at an 
extremely high dose rate (up to 20kGy/sec) to best exploit 
the dose volume effect with peak entrance dose values well 
above several hundreds of Gy, demonstrating a very high 
normal tissue tolerance even for the immature tissue [3]. The 
differential effects[4] between normal tissue vasculature and 
tumor vascular networks promote this novel approach and 
questions one of the dogmas in radiation therapy: namely, 
that radiation therapy is aiming at a dose distributions with 
the primary goal to maximize the dose at the target, while 
minimizing the dose to the normal tissue in order to generally 
optimize the treatment in cancer therapy. An overview of 
the most important findings in radiation biology as well as 
achievements in Medical Physics will be summarized 
reflecting the current status of the project. 
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Purpose: Therapeutic irradiation of brain cancers is 
associated with severe cognitive deficits in patients who 
survive long enough after irradiation. Radiotherapy-induced 
brain damage and dementia are associated to deficits in 
hippocampal-dependent mechanisms of learning and memory 
[1]. In preclinical rodent models, synchrotron-generated 
arrays of microbeams have shown unprecedented therapeutic 
effect on aggressive tumors of the central nervous system; 
furthermore microbeams are very well tolerated by normal 
tissues [2,3]. This latter effect is due to a minimal dose 
spreading outside the microbeam path. Recently, we showed 
that irradiation of the sensorimotor cortex of epileptic rats 
with synchrotron-generated microbeams reduces seizures 
without disrupting neurological functions [4]. Here we 
explored the long-term effects of microbeam versus 
broadbeam irradiation on hippocampal neurogenesis.  
Materials/Methods: Two groups of male Wistar rats (175-200 
g, two months of age) were irradiated with 5 or 10 Gy 
broadbeams, 3 groups were irradiated with 9 parallel 
microbeam arrays (75 μm wide, spaced 200 μm center-to-
center; peak entrance dose: 150, 300 or 600 Gy). The control 
group was not irradiated. Eight months later, we assessed 
cognitive functions by the Morris water maze, depressive-like 
